5,5-dimethylthiazolidine-4-carboxylic acid: used as a proline analog in spectroscopic studies; RN given refers to parent cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 85822 |
| CHEBI ID | 194751 |
| SCHEMBL ID | 190446 |
| MeSH ID | M0180283 |
| Synonym |
|---|
| IDI1_015695 |
| 4-thiazolidinecarboxylic acid,5-dimethyl- |
| nsc-151747 |
| nsc151747 |
| 15260-83-0 |
| MAYBRIDGE3_004308 , |
| HMS1443D18 |
| 39254-94-9 |
| FT-0667563 |
| 5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
| 5,5-dimethyl-1,3-thiazolane-4-carboxylic acid |
| CHEBI:194751 |
| thiazolidine-4-carboxylic acid, 5,5-dimethyl- |
| einecs 239-305-0 |
| 5,5-dimethylthiazolidine-4-carboxylic acid |
| nsc 151747 |
| 4-thiazolidinecarboxylicacid, 5,5-dimethyl- |
| 5,5-dimethyl-1,3-thiazolidine4-carboxylic acid |
| SCHEMBL190446 |
| 5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid # |
| d-5,5'-dimethyl thiazolidine-4-carboxylic acid |
| h-beta,beta-dimethyl-d-cys-oh;h-beta-mercapto-d-val-oh |
| 4-carboxy-5,5-dimethylthiazolidine |
| BCP30964 |
| l-5,5-dimethylthiazolidine-4-carboxylic acidd |
| (r)-5,5-dimethylthiazolidine-4-carboxylic acid pound>>(4r)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
| 5,5-dimethylthiazolidine-4-carboxylicacid |
| (r)-4-carboxy-5,5-dimethylthiazolidine |
| (rs)-4-carboxy-5,5-dimethylthiazolidine |
| DTXSID60902718 |
| noname_3267 |
| F79807 |
| SB44798 |
| SB44827 |
| EN300-186616 |
| Class | Description |
|---|---|
| organonitrogen compound | Any heteroorganic entity containing at least one carbon-nitrogen bond. |
| organooxygen compound | An organochalcogen compound containing at least one carbon-oxygen bond. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||